Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition
Sandra Cascio, Chelsea Chandler, Linan Zhang, et al.
Science Advances (2021) Vol. 7, Iss. 46
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

TGF-β, EMT, and resistance to anti-cancer treatment
Xuecong Wang, Pieter J.A. Eichhorn, Jean Paul Thiery
Seminars in Cancer Biology (2023) Vol. 97, pp. 1-11
Open Access | Times Cited: 54
Drug resistance in ovarian cancer: from mechanism to clinical trial
Ling Wang, Xin Wang, Xueping Zhu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 54
Recent developments in immunotherapy for gastrointestinal tract cancers
Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 21
Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment
Len Frisbie, Ronald J. Buckanovich, Lan Coffman
Stem Cells (2022) Vol. 40, Iss. 8, pp. 705-715
Open Access | Times Cited: 69
Reprogramming of T cell‐derived small extracellular vesicles using IL2 surface engineering induces potent anti‐cancer effects through miRNA delivery
Dokyung Jung, Sanghee Shin, Sung‐Min Kang, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 59
Berberine suppresses colorectal cancer by regulation of Hedgehog signaling pathway activity and gut microbiota
Qiang Sun, Han Yang, Maolun Liu, et al.
Phytomedicine (2022) Vol. 103, pp. 154227-154227
Closed Access | Times Cited: 49
Emerging Roles of Hedgehog Signaling in Cancer Immunity
Alessandro Giammona, Enrica Crivaro, Barbara Stecca
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1321-1321
Open Access | Times Cited: 33
Fibroblasts as Turned Agents in Cancer Progression
Robert Wieder
Cancers (2023) Vol. 15, Iss. 7, pp. 2014-2014
Open Access | Times Cited: 28
Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors
Anna Pawłowska, Anna K. Rekowska, Weronika Kuryło, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10859-10859
Open Access | Times Cited: 25
Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer
Linan Zhang, Sandra Cascio, John W. Mellors, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 11
Macrophage plasticity and function in cancer and pregnancy
Tingxuan Yin, Xinyi Li, Yanhong Li, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 9
Mesenchymal stromal cells as cancer promoters
Roula Antoon, Nina Overdevest, Amr H. Saleh, et al.
Oncogene (2024) Vol. 43, Iss. 49, pp. 3545-3555
Open Access | Times Cited: 9
Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells, Obesity and the Tumor Microenvironment of Breast Cancer
Andreas Ritter, Nina‐Naomi Kreis, Samira Catharina Hoock, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3908-3908
Open Access | Times Cited: 37
The emerging roles of Hedgehog signaling in tumor immune microenvironment
Juan Wang, Baiping Cui, Xiaojie Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 20
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
Claire F. Friedman, Beryl Manning‐Geist, Qin Zhou, et al.
Nature Medicine (2024) Vol. 30, Iss. 5, pp. 1330-1338
Open Access | Times Cited: 8
The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions
Ian P. MacFawn, Grant Magnon, Grace Gorecki, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1864-1881.e5
Closed Access | Times Cited: 8
TGFBI: A novel therapeutic target for cancer
Huimei Huang, Qinglai Tang, Shisheng Li, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112180-112180
Closed Access | Times Cited: 7
Artificial intelligence in ovarian cancer drug resistance advanced 3PM approach: subtype classification and prognostic modeling
Cong Zhang, Jinxiang Yang, Siyu Chen, et al.
The EPMA Journal (2024) Vol. 15, Iss. 3, pp. 525-544
Closed Access | Times Cited: 6
Transforming growth factor‐β signalling in tumour resistance to the anti‐PD‐(L)1 therapy: Updated
Keywan Mortezaee, Jamal Majidpoor
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 3, pp. 311-321
Open Access | Times Cited: 14
Aberrant angiogenic signaling pathways: Accomplices in ovarian cancer progression and treatment
Wenchao Zhou, Tian Zeng, Junling Chen, et al.
Cellular Signalling (2024) Vol. 120, pp. 111240-111240
Closed Access | Times Cited: 6
Carcinoma-associated mesenchymal stem cells promote ovarian cancer heterogeneity and metastasis through mitochondrial transfer
Leonard Frisbie, Catherine A. Pressimone, Emma Dyer, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114551-114551
Open Access | Times Cited: 6
ITGB6 modulates resistance to anti-CD276 therapy in head and neck cancer by promoting PF4+ macrophage infiltration
Caihua Zhang, Kang Li, Hongzhang Zhu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells
Huda I. Atiya, Grace Gorecki, Geyon L. Garcia, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1604-1604
Open Access | Times Cited: 13
Aggresome formation promotes ASK1/JNK signaling activation and stemness maintenance in ovarian cancer
Yurou Chen, Yulong Qiang, Jiachen Fan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Chiral Supramolecular Nanofibers Regulated Tumor‐Derived Exosomes Secretion for Constructing an Anti‐Tumor Extracellular Microenvironment
Beibei Wu, Xiaoqiu Dou, Yu Zhao, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top